Citigroup Inc. Files Q3 2026 Form 13F Holdings Report

Executive Summary

Citigroup Inc. filed its quarterly Form 13F-HR for the reporting period ended September 30, 2026. As an institutional investment manager, Citigroup disclosed holdings managed across 10 affiliated entities, including Citibank, N.A., Citigroup Global Markets Inc., and Citigroup Global Markets Ltd.

Portfolio Overview

• Reporting Period: Q3 2026 (ended September 30, 2026)
• Total Portfolio Market Value: $308,299,622,766
• Total Disclosed Entries: 12,011 positions
• Discretion: Defined discretion split among affiliated subsidiaries and operating broker-dealers

Key Holdings Sampled in Excerpt

• Mega-Cap Core Holdings: Significant equity and options exposure across major corporate equities including AbbVie Inc. (ABBV), Abbott Laboratories (ABT), and AT&T Inc. (T).
• Derivatives Positions: Large option hedges and directional overlays including put/call contracts on names such as ABBV, ABT, T, AFL, and ASTS.
• ETF & Thematic Holdings: Positions in thematic ETFs such as ARK Innovation ETF (ARKK), ARK Genomic Revolution ETF (ARKG), and ALPS Alerian MLP ETF (AMLP).

Significance Assessment

Form 13F filings reflect institutional holdings as of the quarter-end date and do not indicate individual insider buying or selling activity. Trading significance is assessed as Low for immediate insider trading signals, though valuable for institutional positioning analysis.